Fate Therapeutics, Inc. Competitors

FATE 
$5.955
*  
0.195
3.17%
Get FATE Alerts
*Delayed - data as of Apr. 24, 2015  -  Find a broker to begin trading FATE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Fate Therapeutics, Inc.

CompanyName
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap ▼
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 103.695 -1.51 ▼ 9,729,089 $ 105.68
$ 103.60
$ 116.83
$ 71.63
14.05 154,443,540,390
Amgen Inc.
AMGN: NASDAQ-GS
$ 167.91 -1.26 ▼ 2,547,195 $ 169.25
$ 166.06
$ 173.60
$ 108.20
22.66 127,420,350,510
Biogen Inc.
BIIB: NASDAQ-GS
$ 401.71 -28.57 ▼ 6,083,510 $ 410.87
$ 395
$ 480.18
$ 275.3925
32.42 94,246,789,940
Qiagen N.V.
QGEN: NASDAQ-GS
$ 24.83 -0.07 ▼ 471,892 $ 25
$ 24.76
$ 25.91
$ 20.53
50.67 5,794,204,650
Juno Therapeutics, Inc.
JUNO: NASDAQ-GS
$ 56.66 -1.06 ▼ 886,105 $ 58.89
$ 56.04
$ 66
$ 34.71
NE 5,123,537,160
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 37.14 -0.36 ▼ 793,942 $ 38.29
$ 37.12
$ 44.95
$ 30.05
NE 4,617,207,660
bluebird bio, Inc.
BLUE: NASDAQ-GS
$ 136.26 -3.82 ▼ 439,124 $ 140.925
$ 136
$ 141.48
$ 17.40
NE 4,437,443,160
Synageva BioPharma Corp.
GEVA: NASDAQ-GS
$ 108.51 0.92 ▲ 305,982 $ 109.36
$ 106.27
$ 122.88
$ 60.19
NE 4,010,312,580
Bio-Techne Corp
TECH: NASDAQ-GS
$ 100.85 -1.88 ▼ 136,061 $ 103
$ 100.73
$ 102.85
$ 83.83
32.53 3,744,963,900
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 43.37 -0.31 ▼ 358,630 $ 44.10
$ 43.01
$ 45.36
$ 12.6325
NE 3,695,384,220
Kite Pharma, Inc.
KITE: NASDAQ-GS
$ 60.58 -0.35 ▼ 807,303 $ 62.80
$ 59.34
$ 89.21
$ 21
NE 2,575,922,180
China Biologic Products, Inc.
CBPO: NASDAQ-GS
$ 98.59 -0.35 ▼ 21,063 $ 99.66
$ 97.77
$ 102.80
$ 33.49
36.11 2,430,933,630
Novavax, Inc.
NVAX: NASDAQ-GS
$ 8.58 -0.07 ▼ 2,408,748 $ 8.81
$ 8.58
$ 9.95
$ 3.70
NE 2,298,110,100
Halozyme Therapeutics, Inc.
HALO: NASDAQ-GS
$ 16.86 -0.09 ▼ 1,408,079 $ 17.27
$ 16.53
$ 17
$ 6.88
NE 2,114,024,820
ARIAD Pharmaceuticals, Inc.
ARIA: NASDAQ-GS
$ 9.71 0.10 ▲ 5,506,477 $ 9.89
$ 9.54
$ 9.67
$ 4.90
NE 1,817,828,520
Spark Therapeutics, Inc.
ONCE: NASDAQ-GS
$ 61.39 -0.66 ▼ 118,275 $ 63
$ 60.02
$ 79.50
$ 40.16
NE 1,506,756,160
Atara Biotherapeutics, Inc.
ATRA: NASDAQ-GS
$ 59.89 -4.13 ▼ 274,478 $ 64.35
$ 59.5787
$ 64.17
$ 9.66
NE 1,458,920,400
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 33.12 -0.38 ▼ 409,780 $ 33.64
$ 33.06
$ 45.45
$ 28.26
78.86 1,410,084,000
PDL BioPharma, Inc.
PDLI: NASDAQ-GS
$ 7.02 -0.09 ▼ 4,104,260 $ 7.10
$ 6.98
$ 10.26
$ 6.52
3.71 1,142,512,020
Repligen Corporation
RGEN: NASDAQ-GS
$ 34.75 -0.25 ▼ 273,733 $ 35.16
$ 34.46
$ 35.47
$ 14.92
139 1,137,089,500
Momenta Pharmaceuticals, Inc.
MNTA: NASDAQ-GS
$ 20.13 0.04 ▲ 1,149,139 $ 20.30
$ 19.57
$ 20.43
$ 9.38
NE 1,106,606,490
Cellectis S.A.
CLLS: NASDAQ-GM
$ 32.61 -0.07 ▼ 118,055 $ 32.82
$ 31.90
$ 42.04
$ 30.40
NE 1,075,119,090
Acceleron Pharma Inc.
XLRN: NASDAQ-GM
$ 33.29 -0.95 ▼ 85,031 $ 34.75
$ 33.22
$ 48.50
$ 23.61
NE 1,073,702,370
Sangamo BioSciences, Inc.
SGMO: NASDAQ-GS
$ 14.70 -0.84 ▼ 825,391 $ 15.6859
$ 14.70
$ 19.25
$ 9.39
NE 1,016,799,000
DBV Technologies S.A.
DBVT: NASDAQ-GS
$ 26.29 0.42 ▲ 46,068 $ 26.34
$ 25.78
$ 28.50
$ 20.2601
NE 969,838,100